-
1
-
-
0036086034
-
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex
-
Chou J.Y., Matern D., Mansfield B.C., and Chen Y.-T. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2 (2002) 121-143
-
(2002)
Curr. Mol. Med.
, vol.2
, pp. 121-143
-
-
Chou, J.Y.1
Matern, D.2
Mansfield, B.C.3
Chen, Y.-T.4
-
2
-
-
0000171986
-
Glycogen storage diseases
-
Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds), McGraw-Hill, New York
-
Chen Y.-T. Glycogen storage diseases. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eighth ed. (2001), McGraw-Hill, New York 1521-1551
-
(2001)
The Metabolic and Molecular Bases of Inherited Disease. eighth ed.
, pp. 1521-1551
-
-
Chen, Y.-T.1
-
3
-
-
0023203920
-
Plasma and lipoprotein fatty acid composition in glycogen storage disease type I
-
Levy E., Letarte J., Lepage G., Thibault L., and Roy C.C. Plasma and lipoprotein fatty acid composition in glycogen storage disease type I. Lipids 22 (1987) 381-385
-
(1987)
Lipids
, vol.22
, pp. 381-385
-
-
Levy, E.1
Letarte, J.2
Lepage, G.3
Thibault, L.4
Roy, C.C.5
-
4
-
-
0023868754
-
Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding
-
Levy E., Thibault L.A., Roy C.C., Bendayan M., Lepage G., and Letarte J. Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding. J. Lipid. Res. 29 (1988) 215-226
-
(1988)
J. Lipid. Res.
, vol.29
, pp. 215-226
-
-
Levy, E.1
Thibault, L.A.2
Roy, C.C.3
Bendayan, M.4
Lepage, G.5
Letarte, J.6
-
5
-
-
0024519536
-
Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins
-
Fernandes J., Alaupovic P., and Wit J.M. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr. Res. 25 (1989) 327-331
-
(1989)
Pediatr. Res.
, vol.25
, pp. 327-331
-
-
Fernandes, J.1
Alaupovic, P.2
Wit, J.M.3
-
6
-
-
0028003996
-
Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a
-
Lee P.J., Celermajer D.S., Robinson J., McCarthy S.N., Betteridge D.J., and Leonard J.V. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110 (1994) 95-100
-
(1994)
Atherosclerosis
, vol.110
, pp. 95-100
-
-
Lee, P.J.1
Celermajer, D.S.2
Robinson, J.3
McCarthy, S.N.4
Betteridge, D.J.5
Leonard, J.V.6
-
7
-
-
0036387470
-
Is glycogen storage disease 1a associated with atherosclerosis?
-
Ubels F.L., Rake J.P., Slaets J.P., Smit G.P., and Smit A.J. Is glycogen storage disease 1a associated with atherosclerosis?. Eur. J. Pediatr. 161 Suppl. 1 (2002) S62-S64
-
(2002)
Eur. J. Pediatr.
, vol.161
, Issue.SUPPL. 1
-
-
Ubels, F.L.1
Rake, J.P.2
Slaets, J.P.3
Smit, G.P.4
Smit, A.J.5
-
9
-
-
0038705071
-
Importance of different pathways of cellular cholesterol efflux
-
Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 712-719
-
(2003)
Arterioscler. Thromb. Vasc. Biol.
, vol.23
, pp. 712-719
-
-
Yancey, P.G.1
Bortnick, A.E.2
Kellner-Weibel, G.3
de la Llera-Moya, M.4
Phillips, M.C.5
Rothblat, G.H.6
-
10
-
-
0032489436
-
Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors
-
Jian B., de la Llera-Moya M., Ji Y., Wang N., Phillips M.C., Swaney J.B., Tall A.R., and Rothblat G.H. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J. Biol. Chem. 273 (1998) 5599-5606
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 5599-5606
-
-
Jian, B.1
de la Llera-Moya, M.2
Ji, Y.3
Wang, N.4
Phillips, M.C.5
Swaney, J.B.6
Tall, A.R.7
Rothblat, G.H.8
-
11
-
-
2642521483
-
Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids
-
Connelly M.A., and Williams D.L. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr. Opin. Lipidol. 15 (2004) 287-295
-
(2004)
Curr. Opin. Lipidol.
, vol.15
, pp. 287-295
-
-
Connelly, M.A.1
Williams, D.L.2
-
12
-
-
0031442545
-
HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum
-
Fournier N., Paul J.L., Atger V., Cogny A., Soni T., de la Llera-Moya M., Rothblat G., and Moatti N. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2685-2691
-
(1997)
Arterioscler. Thromb. Vasc. Biol.
, vol.17
, pp. 2685-2691
-
-
Fournier, N.1
Paul, J.L.2
Atger, V.3
Cogny, A.4
Soni, T.5
de la Llera-Moya, M.6
Rothblat, G.7
Moatti, N.8
-
13
-
-
1242297079
-
In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux
-
Yancey P.G., Kawashiri M.A., Moore R., Glick J.M., Williams D.L., Connelly M.A., Rader D.J., and Rothblat G.H. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux. J. Lipid. Res. 45 (2004) 337-346
-
(2004)
J. Lipid. Res.
, vol.45
, pp. 337-346
-
-
Yancey, P.G.1
Kawashiri, M.A.2
Moore, R.3
Glick, J.M.4
Williams, D.L.5
Connelly, M.A.6
Rader, D.J.7
Rothblat, G.H.8
-
14
-
-
2342417699
-
The antioxidants and pro-antioxidants network: an overview
-
Vertuani S., Angusti A., and Manfredini S. The antioxidants and pro-antioxidants network: an overview. Curr. Pharm. Des. 10 (2004) 1677-1694
-
(2004)
Curr. Pharm. Des.
, vol.10
, pp. 1677-1694
-
-
Vertuani, S.1
Angusti, A.2
Manfredini, S.3
-
15
-
-
0343247737
-
Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men
-
Nyyssonen K., Porkkala-Sarataho E., Kaikkonen J., and Salonen J.T. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis 130 (1997) 223-233
-
(1997)
Atherosclerosis
, vol.130
, pp. 223-233
-
-
Nyyssonen, K.1
Porkkala-Sarataho, E.2
Kaikkonen, J.3
Salonen, J.T.4
-
16
-
-
0032212580
-
Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro
-
Schlotte V., Sevanian A., Hochstein P., and Weithmann K.U. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Radic. Biol. Med. 25 (1998) 839-847
-
(1998)
Free Radic. Biol. Med.
, vol.25
, pp. 839-847
-
-
Schlotte, V.1
Sevanian, A.2
Hochstein, P.3
Weithmann, K.U.4
-
17
-
-
0036387433
-
Radical trapping in glycogen storage disease 1a
-
Wittenstein B., Klein M., Finckh B., Ullrich K., and Kohlschutter A. Radical trapping in glycogen storage disease 1a. Eur. J. Pediatr. 161 Suppl. 1 (2002) S70-S74
-
(2002)
Eur. J. Pediatr.
, vol.161
, Issue.SUPPL. 1
-
-
Wittenstein, B.1
Klein, M.2
Finckh, B.3
Ullrich, K.4
Kohlschutter, A.5
-
18
-
-
0020004724
-
2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
-
2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28 (1982) 1379-1388
-
(1982)
Clin. Chem.
, vol.28
, pp. 1379-1388
-
-
Warnick, G.R.1
Benderson, J.2
Albers, J.J.3
-
19
-
-
0030868610
-
Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
-
Ji Y., Jian B., Wang N., Sun Y., Moya M.L., Phillips M.C., Rothblat G.H., Swaney J.B., and Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272 (1997) 20982-20985
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 20982-20985
-
-
Ji, Y.1
Jian, B.2
Wang, N.3
Sun, Y.4
Moya, M.L.5
Phillips, M.C.6
Rothblat, G.H.7
Swaney, J.B.8
Tall, A.R.9
-
20
-
-
0034100119
-
The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism
-
Trigatt B., Rigott A., and Krieger M. The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism. Curr. Opin. Lipidol. 11 (2000) 123-131
-
(2000)
Curr. Opin. Lipidol.
, vol.11
, pp. 123-131
-
-
Trigatt, B.1
Rigott, A.2
Krieger, M.3
-
21
-
-
0034705071
-
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
-
Chinetti G., Gbaguidi F.G., Griglio S., Mallat Z., Antonucci M., Poulain P., Chapman J., Fruchart J.C., Tedgui A., Najib-Fruchart J., and Staels B. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101 (2000) 2411-2417
-
(2000)
Circulation
, vol.101
, pp. 2411-2417
-
-
Chinetti, G.1
Gbaguidi, F.G.2
Griglio, S.3
Mallat, Z.4
Antonucci, M.5
Poulain, P.6
Chapman, J.7
Fruchart, J.C.8
Tedgui, A.9
Najib-Fruchart, J.10
Staels, B.11
-
22
-
-
0037155049
-
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice
-
Braun A., Trigatti B.L., Post M.J., Sato K., Simons M., Edelberg J.M., Rosenberg R.D., Schrenzel M., and Krieger M. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90 (2002) 270-276
-
(2002)
Circ. Res.
, vol.90
, pp. 270-276
-
-
Braun, A.1
Trigatti, B.L.2
Post, M.J.3
Sato, K.4
Simons, M.5
Edelberg, J.M.6
Rosenberg, R.D.7
Schrenzel, M.8
Krieger, M.9
-
23
-
-
0034060299
-
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse
-
Kozarsky K.F., Donahee M.H., Glick J.M., Krieger M., and Rader D.J. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 721-727
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 721-727
-
-
Kozarsky, K.F.1
Donahee, M.H.2
Glick, J.M.3
Krieger, M.4
Rader, D.J.5
-
24
-
-
0242266978
-
Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice
-
Zhang W., Yancey P.G., Su Y.R., Babaev V.R., Zhang Y., Fazio S., and Linton M.F. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108 (2003) 2258-2263
-
(2003)
Circulation
, vol.108
, pp. 2258-2263
-
-
Zhang, W.1
Yancey, P.G.2
Su, Y.R.3
Babaev, V.R.4
Zhang, Y.5
Fazio, S.6
Linton, M.F.7
-
25
-
-
0041527450
-
Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells
-
Covey S.D., Krieger M., Wang W., Penman M., and Trigatti B.L. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1589-1594
-
(2003)
Arterioscler. Thromb. Vasc. Biol.
, vol.23
, pp. 1589-1594
-
-
Covey, S.D.1
Krieger, M.2
Wang, W.3
Penman, M.4
Trigatti, B.L.5
-
26
-
-
24044525002
-
Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: a potential mechanism that protects against premature atherosclerosis
-
Nguyen A.D., Pan C.-J., Shieh J.J., and Chou J.Y. Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: a potential mechanism that protects against premature atherosclerosis. FEBS Lett. 579 (2005) 4713-4718
-
(2005)
FEBS Lett.
, vol.579
, pp. 4713-4718
-
-
Nguyen, A.D.1
Pan, C.-J.2
Shieh, J.J.3
Chou, J.Y.4
-
27
-
-
25444463073
-
ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease
-
Oram J.F., and Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85 (2005) 1343-1372
-
(2005)
Physiol. Rev.
, vol.85
, pp. 1343-1372
-
-
Oram, J.F.1
Heinecke, J.W.2
-
28
-
-
0029791322
-
Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
-
Duverger N., Tremp G., Caillaud J.M., Emmanuel F., Castro G., Fruchart J.C., Steinmetz A., and Denefle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273 (1996) 966-968
-
(1996)
Science
, vol.273
, pp. 966-968
-
-
Duverger, N.1
Tremp, G.2
Caillaud, J.M.3
Emmanuel, F.4
Castro, G.5
Fruchart, J.C.6
Steinmetz, A.7
Denefle, P.8
-
29
-
-
0030944085
-
Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV
-
Cohen R.D., Castellani L.W., Qiao J.H., Van Lenten B.J., Lusis A.J., and Reue K. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest. 99 (1997) 1906-1916
-
(1997)
J. Clin. Invest.
, vol.99
, pp. 1906-1916
-
-
Cohen, R.D.1
Castellani, L.W.2
Qiao, J.H.3
Van Lenten, B.J.4
Lusis, A.J.5
Reue, K.6
-
30
-
-
0037450914
-
Apo A-IV: an update on regulation and physiologic functions
-
Stan S., Delvin E., Lambert M., Seidman E., and Levy E. Apo A-IV: an update on regulation and physiologic functions. Biochim. Biophys. Acta 1631 (2003) 177-187
-
(2003)
Biochim. Biophys. Acta
, vol.1631
, pp. 177-187
-
-
Stan, S.1
Delvin, E.2
Lambert, M.3
Seidman, E.4
Levy, E.5
-
31
-
-
1542614443
-
Cardiovascular drugs and serum uric acid
-
Reyes A.J. Cardiovascular drugs and serum uric acid. Cardiovasc. Drugs Ther. 17 (2003) 397-414
-
(2003)
Cardiovasc. Drugs Ther.
, vol.17
, pp. 397-414
-
-
Reyes, A.J.1
-
32
-
-
19544363918
-
The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure
-
Reyes A.J. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur. J. Heart Fail. 7 (2005) 461-467
-
(2005)
Eur. J. Heart Fail.
, vol.7
, pp. 461-467
-
-
Reyes, A.J.1
-
34
-
-
0347933047
-
Inhibition by uric acid of free radicals that damage biological molecules
-
Muraoka S., and Miura T. Inhibition by uric acid of free radicals that damage biological molecules. Pharmacol. Toxicol. 93 (2003) 284-289
-
(2003)
Pharmacol. Toxicol.
, vol.93
, pp. 284-289
-
-
Muraoka, S.1
Miura, T.2
|